Drug Shortage Report for NOZINAN
| Report ID | 18692 |
| Drug Identification Number | 01927698 |
| Brand name | NOZINAN INJ 25MG/ML |
| Common or Proper name | Nozinan solution injectable 25 mg/ml |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METHOTRIMEPRAZINE |
| Strength(s) | 25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10 |
| ATC code | N05AA |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2017-09-15 |
| Actual start date | |
| Estimated end date | 2017-11-03 |
| Actual end date | 2017-11-09 |
| Shortage status | Resolved |
| Updated date | 2017-11-10 |
| Company comments | Manufacturing delay |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2017-11-10 | French | Compare |
| v8 | 2017-11-10 | English | Compare |
| v7 | 2017-10-03 | French | Compare |
| v6 | 2017-10-03 | English | Compare |
| v5 | 2017-10-03 | French | Compare |
| v4 | 2017-10-03 | English | Compare |
| v3 | 2017-09-16 | English | Compare |
| v2 | 2017-08-10 | French | Compare |
| v1 | 2017-08-10 | English | Compare |
Showing 1 to 9 of 9